Next Article in Journal
Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A Streptococcus
Next Article in Special Issue
The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next Steps
Previous Article in Journal
Alum/CpG Adjuvanted Inactivated COVID-19 Vaccine with Protective Efficacy against SARS-CoV-2 and Variants
Previous Article in Special Issue
A U.S. Government-Coordinated Effort to Leverage Non-Human Primate Data to Facilitate Ebolavirus Vaccine Development
 
 
Article

Article Versions Notes

Vaccines 2022, 10(8), 1211; https://doi.org/10.3390/vaccines10081211
Action Date Notes Link
article xml file uploaded 29 July 2022 12:44 CEST Original file -
article xml uploaded. 29 July 2022 12:44 CEST Update -
article pdf uploaded. 29 July 2022 12:44 CEST Version of Record https://www.mdpi.com/2076-393X/10/8/1211/pdf-vor
article supplementary file uploaded. 29 July 2022 12:44 CEST - https://www.mdpi.com/2076-393X/10/8/1211#supplementary
article html file updated 29 July 2022 12:46 CEST Original file -
article xml file uploaded 4 August 2022 11:06 CEST Update -
article xml uploaded. 4 August 2022 11:06 CEST Update https://www.mdpi.com/2076-393X/10/8/1211/xml
article pdf uploaded. 4 August 2022 11:06 CEST Updated version of record https://www.mdpi.com/2076-393X/10/8/1211/pdf
article html file updated 4 August 2022 11:08 CEST Update -
article html file updated 13 August 2022 04:30 CEST Update https://www.mdpi.com/2076-393X/10/8/1211/html
Back to TopTop